CACLP reported that Mirxes' FITRAPID received Singapore HSA approval to expand into the at-home B2C testing market.

Debuted in 1991, China International In Vitro Diagnostic Expo by CACLP, is well established as one of the largest exhibitions in the in vitro diagnostic industry worldwide. China IVD Supply Chain Expo, successfully launched since 2021, further expand the product sectors from upstream to downstream. The great number of high-level academic and educational programs taking place concurrently onsite and year-round promotional solutions make CACLP one of the most important platforms for global IVD players. Every year, CACLP brings together over 40,000 professionals including entrepreneurs, scholars, users and thought leaders in the clinical laboratory industry around the globe to exchange the latest developments in the industry, enhance the partnerships and shape the future of IVD industry all together. CACLP 2025 looks forward to welcoming IVD professionals from around the globe.